BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 12629189)

  • 1. Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.
    Song B; Marvizón JC
    J Neurosci; 2003 Mar; 23(5):1847-58. PubMed ID: 12629189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce micro-opioid receptor internalization in the rat spinal cord.
    Song B; Marvizón JC
    J Neurosci; 2003 Oct; 23(27):9171-84. PubMed ID: 14534251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.
    Chen W; Song B; Lao L; Pérez OA; Kim W; Marvizón JC
    Neuropharmacology; 2007 Oct; 53(5):664-76. PubMed ID: 17845806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.
    Lao L; Song B; Chen W; Marvizón JC
    Brain Res; 2008 Mar; 1197():85-93. PubMed ID: 18207137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
    Budai D; Fields HL
    J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of three peptidase inhibitors, amastatin, captopril and phosphoramidon, on the hydrolysis of [Met5]-enkephalin-Arg6-Phe7 and other opioid peptides.
    Hiranuma T; Kitamura K; Taniguchi T; Kobayashi T; Tamaki R; Kanai M; Akahori K; Iwao K; Oka T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):276-82. PubMed ID: 9550299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsynaptic signaling via the [mu]-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation.
    Trafton JA; Abbadie C; Marek K; Basbaum AI
    J Neurosci; 2000 Dec; 20(23):8578-84. PubMed ID: 11102461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior.
    Sinchak K; Micevych PE
    J Neurosci; 2001 Aug; 21(15):5723-9. PubMed ID: 11466444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord.
    Song B; Marvizón JC
    Neuroscience; 2005; 136(2):549-62. PubMed ID: 16203108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of veratridine and high potassium on micro-opioid receptor internalization in the rat spinal cord: stimulation of opioid release versus inhibition of internalization.
    Chen W; Song B; Zhang G; Marvizón JC
    J Neurosci Methods; 2008 May; 170(2):285-93. PubMed ID: 18377995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of dynorphin-(1-8) in isolated preparations by three peptidases.
    Numata H; Hiranuma T; Oka T
    Jpn J Pharmacol; 1988 Aug; 47(4):417-23. PubMed ID: 2903264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against dynorphin-(1-8) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon.
    Hiranuma T; Kitamura K; Taniguchi T; Kanai M; Arai Y; Iwao K; Oka T
    J Pharmacol Exp Ther; 1998 Aug; 286(2):863-9. PubMed ID: 9694943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peptidases on the ability of exogenous and endogenous neurokinins to produce neurokinin 1 receptor internalization in the rat spinal cord.
    Marvizon JC; Wang X; Lao LJ; Song B
    Br J Pharmacol; 2003 Dec; 140(8):1389-98. PubMed ID: 14623771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M; Boda K; Gintzler AR
    J Pharmacol Exp Ther; 2004 Jul; 310(1):256-62. PubMed ID: 14996951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of opioid release in the rat spinal cord by alpha2C adrenergic receptors.
    Chen W; Song B; Marvizón JC
    Neuropharmacology; 2008 May; 54(6):944-53. PubMed ID: 18343461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opiates and behavior: 2012.
    Bodnar RJ
    Peptides; 2013 Dec; 50():55-95. PubMed ID: 24126281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D1-like Receptors Regulate Constitutive, μ-Opioid Receptor-Mediated Repression of Use-Dependent Synaptic Plasticity in Dorsal Horn Neurons: More Harm than Good?
    Aira Z; Barrenetxea T; Buesa I; García Del Caño G; Azkue JJ
    J Neurosci; 2016 May; 36(20):5661-73. PubMed ID: 27194343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of peptidases potentiates enkephalin-stimulated contraction of gastric muscle cells.
    Menozzi D; Gu ZF; Maton PN; Bunnett NW
    Am J Physiol; 1991 Sep; 261(3 Pt 1):G476-84. PubMed ID: 1679601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.